TXG   $18.4  0.11% Market Open

10x Genomics, Inc.
Total Cash 398.16M
totalCashPerShare 3.289
EBITDA -134.77M
Total Debt 85.88M
quickRatio 3.973
currentRatio 4.899
Total Revenue 629.74M
debtToEquity 11.881
Revenue/Share 5.261
ROA -0.11372
ROE -0.24870001
grossProfits
freeCashflow 97.40M
operatingCashflow 39.17M
earningsGrowth
revenueGrowth -0.013
grossMargins 0.66632
ebitdaMargins -0.21400999
operatingMargins -0.27355
profitMargins -0.28988
enterpriseValue 1.79B
forwardPE -13.606558
floatShares 104.96M
sharesOutstanding 107.00M
sharesShort 7.65M
sharesShortPriorMonth 7.81M
dateShortInterest
sharesPercentSharesOut 0.06%
heldPercentInsiders 0.02%
heldPercentInstitutions 0.94%
Short Ratio help_outline 3.53%
shortPercentOfFloat 0.08%
impliedSharesOutstanding
bookValue 5.972
Price To Book help_outline 2.78
earningsQuarterlyGrowth
netIncomeToCommon -182.55M
trailingEps -1.52%
forwardEps -1.22%
enterpriseToEbitda -13.26
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.29 4Q 2024
institutionsCount 362
lastUpdated Nov. 7, 2024, 3:03 a.m.